Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07216170 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke

Study acronym: REVIVE
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Withdrawn to Not Yet Recruiting
    • Start date: Feb 2026 to Dec 2026
    • Enrollment target: 0 to 200
    v3
  2. Trial status: Not Yet Recruiting to Withdrawn Sponsor's reason: The study is being withdrawn due to a change in regulatory strategy for market approval.
    • Enrollment target: estimated 200 to confirmed 0
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to evaluate the safety and effectiveness of the SOFIA Flow 88 Aspiration Catheter for treatment of acute ischemic stroke.
Trial Details
NCT Number NCT07216170
Lead Sponsor Microvention-Terumo, Inc.
Collaborators: Bright Research Partners
Conditions
(from sponsor)		 Acute Ischemic Stroke
Related terms Ischemic Stroke
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov